Defining, Treating, and Understanding Chronic Kidney DiseaseA Complex Disorder

被引:14
作者
Campbell, Dean [1 ]
Weir, Matthew R. [2 ]
机构
[1] Univ Maryland, Sch Med, Dept Internal Med, Baltimore, MD 21201 USA
[2] Univ Maryland, Sch Med, Dept Med, Div Nephrol, Baltimore, MD 21201 USA
关键词
GLOMERULAR-FILTRATION-RATE; BLOOD-PRESSURE CONTROL; SERUM URIC-ACID; CONVERTING ENZYME-INHIBITORS; STAGE RENAL-DISEASE; CARDIOVASCULAR-DISEASE; METABOLIC-ACIDOSIS; BARDOXOLONE METHYL; MYOGENIC RESPONSE; RECEPTOR BLOCKERS;
D O I
10.1111/jch.12560
中图分类号
R6 [外科学];
学科分类号
1002 ; 100210 ;
摘要
Chronic kidney disease (CKD) is prevalent in more than 20 million people in the United States. The majority of care provided to patients with this disease comes from primary care physicians, although it is often poorly understood. After an extensive literature review, it is clear that it can be difficult to classify and there are many barriers to care. Risk factors for both incident CKD and disease progression include hypertension, poor glycemic control, sociodemographic factors, acute kidney injury, metabolic acidosis, and possibly hyperuricemia and dietary factors. Treatment of patients with CKD should focus on mitigating risk factors, as well as common comorbidities such as cardiovascular disease, anemia, and bone mineral disease. Novel therapies such as pirfenidone, pentoxifylline, and endothelin-1 antagonists are being investigated with promising results. (C) 2015 Wiley Periodicals, Inc.
引用
收藏
页码:514 / 527
页数:14
相关论文
共 83 条
  • [1] Kidney stones and kidney function loss: a cohort study
    Alexander, R. Todd
    Hemmelgarn, Brenda R.
    Wiebe, Natasha
    Bello, Aminu
    Morgan, Catherine
    Samuel, Susan
    Klarenbach, Scott W.
    Curhan, Gary C.
    Tonelli, Marcello
    [J]. BMJ-BRITISH MEDICAL JOURNAL, 2012, 345
  • [2] Mechanisms of Anemia in CKD
    Babitt, Jodie L.
    Lin, Herbert Y.
    [J]. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2012, 23 (10): : 1631 - 1634
  • [3] The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): a randomised placebo-controlled trial
    Baigent, Colin
    Landray, Martin J.
    Reith, Christina
    Emberson, Jonathan
    Wheeler, David C.
    Tomson, Charles
    Wanner, Christoph
    Krane, Vera
    Cass, Alan
    Craig, Jonathan
    Neal, Bruce
    Jiang, Lixin
    Hooi, Lai Seong
    Levin, Adeera
    Agodoa, Lawrence
    Gaziano, Mike
    Kasiske, Bertram
    Walker, Robert
    Massy, Ziad A.
    Feldt-Rasmussen, Bo
    Krairittichai, Udom
    Ophascharoensuk, Vuddidhej
    Fellstrom, Bengt
    Holdaas, Hallvard
    Tesar, Vladimir
    Wiecek, Andrzej
    Grobbee, Diederick
    de Zeeuw, Dick
    Gronhagen-Riska, Carola
    Dasgupta, Tanaji
    Lewis, David
    Herrington, William
    Mafham, Marion
    Majoni, William
    Wallendszus, Karl
    Grimm, Richard
    Pedersen, Terje
    Tobert, Jonathan
    Armitage, Jane
    Baxter, Alex
    Bray, Christopher
    Chen, Yiping
    Chen, Zhengming
    Hill, Michael
    Knott, Carol
    Parish, Sarah
    Simpson, David
    Sleight, Peter
    Young, Alan
    Collins, Rory
    [J]. LANCET, 2011, 377 (9784) : 2181 - 2192
  • [4] Avosentan is protective in hypertensive nephropathy at doses not causing fluid retention
    Baltatu, Ovidiu C.
    Zaugg, Christian E.
    Schumacher, Christoph
    Louie, Pat
    Campos, Luciana A.
    Bader, Michael
    [J]. PHARMACOLOGICAL RESEARCH, 2014, 80 : 9 - 13
  • [5] Protective Importance of the Myogenic Response in the Renal Circulation
    Bidani, Anil K.
    Griffin, Karen A.
    Williamson, Geoffrey
    Wang, Xuemei
    Loutzenhiser, Rodger
    [J]. HYPERTENSION, 2009, 54 (02) : 393 - 398
  • [6] Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy
    Brenner, BM
    Cooper, ME
    de Zeeuw, D
    Keane, WF
    Mitch, WE
    Parving, HH
    Remuzzi, G
    Snapinn, SM
    Zhang, ZX
    Shahinfar, S
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2001, 345 (12) : 861 - 869
  • [7] Inappropriate drug use and mortality in community-dwelling elderly with impaired kidney function-the Three-City population-based study
    Breton, Gaelle
    Froissart, Marc
    Janus, Nicolas
    Launay-Vacher, Vincent
    Berr, Claudine
    Tzourio, Christophe
    Helmer, Catherine
    Stengel, Benedicte
    [J]. NEPHROLOGY DIALYSIS TRANSPLANTATION, 2011, 26 (09) : 2852 - 2859
  • [8] Antihypertensive Effects of Statins: A Meta-Analysis of Prospective Controlled Studies
    Briasoulis, Alexandros
    Agarwal, Vikram
    Valachis, Antonis
    Messerli, Franz H.
    [J]. JOURNAL OF CLINICAL HYPERTENSION, 2013, 15 (05) : 310 - 320
  • [9] THE CONTRIBUTION OF ACIDOSIS TO RENAL OSTEODYSTROPHY - DISCUSSION
    BUSHINSKY, DA
    MADIAS, NE
    HARRINGTON, JT
    KING, A
    LEMAY, S
    PARKER, M
    [J]. KIDNEY INTERNATIONAL, 1995, 47 (06) : 1816 - 1832
  • [10] Low glomerular filtration rate in normoalbuminuric type 1 dihibetic patients - An indicator of more advanced glomerular lesions
    Caramori, ML
    Fioretto, P
    Mauer, M
    [J]. DIABETES, 2003, 52 (04) : 1036 - 1040